Al-Horani RA, Aliter KF, Aliter HF. Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity. Curr Diabetes Rev. 2024 Jan 23. doi: 10.2174/0115733998276832231124170324. Epub ahead of print. PMID: 38275036.
Jacob, Prasobh; Surendran, Praveen Jayaprabha; E M, Muhamed Aleef; Papasavvas, Theodoros; Praveen, Reshma; Swaminathan, Narasimman; Milligan, Fiona. Early Mobilization of Patients Receiving Vasoactive Drugs in Critical Care Units: A Systematic Review. Journal of Acute Care Physical Therapy 12(1):p 37-48, January 2021. | DOI: 10.1097/JAT.0000000000000140
Laranjo L, Lanas F, Sun MC, Chen DA, Hynes L, Imran TF, Kazi DS, Kengne AP, Komiyama M, Kuwabara M, Lim J, Perel P, Piñeiro DJ, Ponte-Negretti CI, Séverin T, Thompson DR, Tokgözoğlu L, Yan LL, Chow CK. World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update. Glob Heart. 2024 Jan 22;19(1):8. doi: 10.5334/gh.1278. PMID: 38273995; PMCID: PMC10809857.
Pharmacology in Physical Therapist Practice, APTA HOD P06-18-34-39, 2018
Pharmacology in Rehabilitation, Fifth Edition. Charles D. Ciccone, et al. McGraw Hill, 2022
Shankar A, Gurumurthy G, Sridharan L, Gupta D, Nicholson WJ, Jaber WA, Vallabhajosyula S. A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock. Clin Med Insights Cardiol. 2022 Feb 7;16:11795468221075064. doi: 10.1177/11795468221075064. PMID: 35153521; PMCID: PMC8829716.
Waldron C, Hughes J, Wallace E, Cahir C, Bennett K. Contexts and mechanisms relevant to General Practitioner (GP) based interventions to reduce adverse drug events (ADE) in community dwelling older adults: a rapid realist review. HRB Open Res. 2023 Dec 28;5:53. doi: 10.12688/hrbopenres.13580.2. PMID: 38283368; PMCID: PMC10811420.